Vietnam Healthcare Diagnostics and Imaging Market

The Vietnam Healthcare Diagnostics and Imaging Market, valued at USD 1.5 billion, is driven by increasing chronic diseases and technological innovations in imaging and diagnostics.

Region:Asia

Author(s):Dev

Product Code:KRAA7274

Pages:84

Published On:September 2025

About the Report

Base Year 2024

Vietnam Healthcare Diagnostics and Imaging Market Overview

  • The Vietnam Healthcare Diagnostics and Imaging Market is valued at USD 1.5 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and advancements in diagnostic technologies. The demand for accurate and timely diagnostics has surged, leading to a significant investment in imaging and diagnostic equipment across the country.
  • Key cities such as Ho Chi Minh City and Hanoi dominate the market due to their advanced healthcare infrastructure and concentration of medical facilities. These urban centers are home to numerous hospitals and diagnostic laboratories, which facilitate the adoption of innovative healthcare technologies and services, thereby driving market growth.
  • In 2023, the Vietnamese government implemented a regulation mandating the use of advanced imaging technologies in public hospitals to enhance diagnostic accuracy. This regulation aims to improve patient outcomes and streamline healthcare services, reflecting the government's commitment to modernizing the healthcare sector and ensuring access to high-quality diagnostic services.
Vietnam Healthcare Diagnostics and Imaging Market Size

Vietnam Healthcare Diagnostics and Imaging Market Segmentation

By Type:The market is segmented into Imaging Equipment, Diagnostic Reagents, Software Solutions, and Others. Imaging Equipment is the leading sub-segment, driven by the increasing demand for advanced imaging technologies such as MRI and CT scanners. Diagnostic Reagents follow closely, as they are essential for accurate testing and diagnosis. Software Solutions are gaining traction due to the need for efficient data management and analysis in healthcare settings.

Vietnam Healthcare Diagnostics and Imaging Market segmentation by Type.

By End-User:The market is categorized into Hospitals, Diagnostic Laboratories, Outpatient Clinics, and Others. Hospitals are the dominant end-user segment, accounting for a significant share due to their extensive use of diagnostic imaging and laboratory services. Diagnostic Laboratories also play a crucial role, as they are essential for conducting various tests and analyses. Outpatient Clinics are increasingly adopting diagnostic technologies to provide comprehensive care to patients.

Vietnam Healthcare Diagnostics and Imaging Market segmentation by End-User.

Vietnam Healthcare Diagnostics and Imaging Market Competitive Landscape

The Vietnam Healthcare Diagnostics and Imaging Market is characterized by a dynamic mix of regional and international players. Leading participants such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Hitachi Medical Corporation, Mindray Medical International Limited, Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Agfa-Gevaert Group, Varian Medical Systems, 3M Health Care, Terumo Corporation contribute to innovation, geographic expansion, and service delivery in this space.

Siemens Healthineers

1847

Germany

GE Healthcare

1892

USA

Philips Healthcare

1891

Netherlands

Canon Medical Systems

1930

Japan

Fujifilm Holdings Corporation

1934

Japan

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Diversification Index

Vietnam Healthcare Diagnostics and Imaging Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the Vietnam healthcare diagnostics and imaging market. In future, approximately 16 million adults in Vietnam are projected to be living with diabetes, reflecting a 20% increase from 2020. This growing patient population necessitates advanced diagnostic imaging solutions, thereby driving demand for innovative healthcare technologies and services to manage these conditions effectively.
  • Rising Healthcare Expenditure:Vietnam's healthcare expenditure is expected to reach $22 billion in future, up from $15 billion in 2020. This increase is driven by both government and private sector investments aimed at enhancing healthcare services. The growing financial commitment to healthcare infrastructure and services is fostering the adoption of advanced diagnostic imaging technologies, which are essential for accurate disease detection and management, thus propelling market growth.
  • Technological Advancements in Diagnostic Imaging:The Vietnam healthcare diagnostics market is witnessing rapid technological advancements, particularly in imaging modalities such as MRI and CT scans. By future, the number of MRI machines in Vietnam is expected to increase by 35%, enhancing diagnostic capabilities. These innovations not only improve diagnostic accuracy but also reduce patient wait times, making advanced imaging more accessible and driving overall market growth in the healthcare sector.

Market Challenges

  • High Costs of Advanced Diagnostic Equipment:The high costs associated with advanced diagnostic imaging equipment pose a significant challenge for healthcare providers in Vietnam. For instance, the price of a new MRI machine can exceed $1.2 million, making it difficult for many hospitals, especially in rural areas, to invest in such technology. This financial barrier limits access to essential diagnostic services, hindering overall market growth and patient care quality.
  • Limited Access to Healthcare in Rural Areas:Approximately 70% of Vietnam's population resides in rural areas, where access to healthcare services remains limited. In future, it is estimated that only 32% of rural healthcare facilities will have access to advanced diagnostic imaging technologies. This disparity creates significant challenges in providing timely and effective healthcare, leading to delayed diagnoses and treatment, which ultimately affects the overall healthcare outcomes in these regions.

Vietnam Healthcare Diagnostics and Imaging Market Future Outlook

The Vietnam healthcare diagnostics and imaging market is poised for significant transformation driven by technological advancements and increasing healthcare investments. As the government continues to enhance healthcare infrastructure, the integration of artificial intelligence in diagnostic processes is expected to streamline operations and improve accuracy. Additionally, the expansion of telemedicine services will facilitate remote diagnostics, making healthcare more accessible. These trends indicate a promising future for the market, with a focus on improving patient outcomes and healthcare delivery efficiency.

Market Opportunities

  • Expansion of Telemedicine Services:The growth of telemedicine services presents a significant opportunity for the diagnostics market. By future, telemedicine consultations are projected to increase by 45%, allowing patients in remote areas to access diagnostic services without traveling long distances. This shift not only enhances patient convenience but also drives demand for remote diagnostic imaging solutions, creating new revenue streams for healthcare providers.
  • Growth in Private Healthcare Facilities:The rise of private healthcare facilities in Vietnam is creating new opportunities for diagnostic imaging services. By future, the number of private hospitals is expected to increase by 30%, leading to greater competition and improved service offerings. This growth will likely drive investments in advanced diagnostic technologies, enhancing the overall quality of healthcare services available to the population.

Scope of the Report

SegmentSub-Segments
By Type

Imaging Equipment

Diagnostic Reagents

Software Solutions

Others

By End-User

Hospitals

Diagnostic Laboratories

Outpatient Clinics

Others

By Application

Oncology

Cardiology

Neurology

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Region

Northern Vietnam

Central Vietnam

Southern Vietnam

Others

By Price Range

Low-End

Mid-Range

High-End

By Technology

MRI

CT Scanners

Ultrasound

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Vietnam Food Administration)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Device Importers and Exporters

Industry Associations (e.g., Vietnam Medical Equipment Association)

Health Insurance Companies

Players Mentioned in the Report:

Siemens Healthineers

GE Healthcare

Philips Healthcare

Canon Medical Systems

Fujifilm Holdings Corporation

Hitachi Medical Corporation

Mindray Medical International Limited

Roche Diagnostics

Abbott Laboratories

Becton, Dickinson and Company

Hologic, Inc.

Agfa-Gevaert Group

Varian Medical Systems

3M Health Care

Terumo Corporation

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Vietnam Healthcare Diagnostics and Imaging Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Vietnam Healthcare Diagnostics and Imaging Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Vietnam Healthcare Diagnostics and Imaging Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic diseases
3.1.2 Rising healthcare expenditure
3.1.3 Technological advancements in diagnostic imaging
3.1.4 Government initiatives to improve healthcare infrastructure

3.2 Market Challenges

3.2.1 High costs of advanced diagnostic equipment
3.2.2 Limited access to healthcare in rural areas
3.2.3 Regulatory hurdles in market entry
3.2.4 Shortage of skilled healthcare professionals

3.3 Market Opportunities

3.3.1 Expansion of telemedicine services
3.3.2 Growth in private healthcare facilities
3.3.3 Increasing demand for preventive healthcare
3.3.4 Collaborations with international healthcare organizations

3.4 Market Trends

3.4.1 Shift towards personalized medicine
3.4.2 Integration of AI in diagnostic processes
3.4.3 Rise of point-of-care testing
3.4.4 Focus on patient-centric healthcare solutions

3.5 Government Regulation

3.5.1 Implementation of health technology assessment (HTA)
3.5.2 Stricter quality control measures for medical devices
3.5.3 Policies promoting public-private partnerships
3.5.4 Regulations on data privacy in healthcare

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Vietnam Healthcare Diagnostics and Imaging Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Vietnam Healthcare Diagnostics and Imaging Market Segmentation

8.1 By Type

8.1.1 Imaging Equipment
8.1.2 Diagnostic Reagents
8.1.3 Software Solutions
8.1.4 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Diagnostic Laboratories
8.2.3 Outpatient Clinics
8.2.4 Others

8.3 By Application

8.3.1 Oncology
8.3.2 Cardiology
8.3.3 Neurology
8.3.4 Others

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Distributors
8.4.3 Online Sales
8.4.4 Others

8.5 By Region

8.5.1 Northern Vietnam
8.5.2 Central Vietnam
8.5.3 Southern Vietnam
8.5.4 Others

8.6 By Price Range

8.6.1 Low-End
8.6.2 Mid-Range
8.6.3 High-End

8.7 By Technology

8.7.1 MRI
8.7.2 CT Scanners
8.7.3 Ultrasound
8.7.4 Others

9. Vietnam Healthcare Diagnostics and Imaging Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Diversification Index
9.2.8 Operational Efficiency Ratio
9.2.9 Brand Recognition Score
9.2.10 Innovation Index

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Siemens Healthineers
9.5.2 GE Healthcare
9.5.3 Philips Healthcare
9.5.4 Canon Medical Systems
9.5.5 Fujifilm Holdings Corporation
9.5.6 Hitachi Medical Corporation
9.5.7 Mindray Medical International Limited
9.5.8 Roche Diagnostics
9.5.9 Abbott Laboratories
9.5.10 Becton, Dickinson and Company
9.5.11 Hologic, Inc.
9.5.12 Agfa-Gevaert Group
9.5.13 Varian Medical Systems
9.5.14 3M Health Care
9.5.15 Terumo Corporation

10. Vietnam Healthcare Diagnostics and Imaging Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Finance
10.1.3 Ministry of Planning and Investment

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Diagnostic Facilities
10.2.2 Budget Allocation for Medical Equipment
10.2.3 Funding for Research and Development

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Diagnostic Laboratories
10.3.3 Outpatient Clinics

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Acceptance Levels
10.4.3 Infrastructure Readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Expansion into New Use Cases
10.5.3 Long-term Sustainability of Solutions

11. Vietnam Healthcare Diagnostics and Imaging Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of healthcare expenditure reports from the Ministry of Health, Vietnam
  • Review of industry publications and market reports from healthcare associations
  • Examination of regulatory frameworks and policies affecting diagnostics and imaging

Primary Research

  • Interviews with healthcare professionals, including radiologists and lab technicians
  • Surveys conducted with hospital administrators and procurement officers
  • Focus groups with patients to understand preferences and experiences with diagnostics

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including government and private sector reports
  • Triangulation of qualitative insights from interviews with quantitative data from surveys
  • Sanity checks through expert panel reviews comprising industry veterans and academic professionals

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare spending in Vietnam and its allocation to diagnostics and imaging
  • Segmentation of the market by imaging modalities (e.g., MRI, CT, X-ray) and diagnostic tests
  • Incorporation of growth trends in telemedicine and home diagnostics into market size calculations

Bottom-up Modeling

  • Collection of data on the number of diagnostic centers and imaging facilities across Vietnam
  • Estimation of average revenue per facility based on service pricing and volume
  • Calculation of market size based on the aggregate of facility-level data

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating demographic trends and disease prevalence rates
  • Scenario modeling based on potential healthcare reforms and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Diagnostic Imaging Facilities100Radiologists, Imaging Technologists
Laboratory Diagnostic Centers80Lab Managers, Pathologists
Healthcare Providers (Hospitals)120Hospital Administrators, Procurement Officers
Patient Experience Surveys150Patients, Caregivers
Telemedicine Service Providers70Telehealth Coordinators, IT Managers

Frequently Asked Questions

What is the current value of the Vietnam Healthcare Diagnostics and Imaging Market?

The Vietnam Healthcare Diagnostics and Imaging Market is valued at approximately USD 1.5 billion, driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and advancements in diagnostic technologies.

Which cities are the primary markets for healthcare diagnostics and imaging in Vietnam?

What recent regulations has the Vietnamese government implemented regarding diagnostic imaging?

What are the main segments of the Vietnam Healthcare Diagnostics and Imaging Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022